iRay Group (SHA:688301)
120.54
-0.31 (-0.26%)
Jun 18, 2026, 3:00 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 35.67 billion as of June 18, 2026. Its market cap has increased by 106.53% in one year.
Market Cap
35.67B
Enterprise Value
37.08B
Revenue
2.46B
Ranking
n/a
PE Ratio
52.76
Stock Price
120.54
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 35.67B, an increase of 207.08%. That is a compound annual growth rate of 21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 35.67B | 67.02% |
| Dec 31, 2025 | 21.35B | 56.38% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gan & Lee Pharmaceuticals. | 33.63B |
| Intco Medical Technology | 29.65B |
| Imeik Technology Development | 28.22B |
| Andon Health | 28.03B |
| Zhende Medical | 22.66B |
| Jiangsu Hualan New Pharmaceutical Material | 19.82B |
| Winner Medical | 16.33B |
| Qingdao NovelBeam Technology | 14.43B |